Topical Application of Chlorhexidine to the Umbilical Cord for Prevention of Omphalitis and Neonatal Mortality in Rural District of Pakistan

Sponsor
Aga Khan University (Other)
Overall Status
Completed
CT.gov ID
NCT00682006
Collaborator
John Snow, Inc. (Industry)
9,800
1
4
23
426.1

Study Details

Study Description

Brief Summary

The investigators hypothesize that application of 4% Chlorhexidine to the cord stump and meticulous hand washing by primary health care providers of newborn infants will reduce the incidence of Omphalitis and thereby Neonatal Mortality as compared to standardized dry cord care.

Condition or Disease Intervention/Treatment Phase
  • Drug: 4% Chlorhexidine
  • Other: Hand washing Soap
  • Drug: 4% Chlorhexidine
Phase 3

Detailed Description

The prime objective of this study is to estimate the independent effect of 4% Chlorhexidine solution application to cord stump and hand washing with soap by mothers of newborns for 2 weeks after birth in reducing Omphalitis in neonates compared to routine cord care by TBAs (Traditional Birth Attendant) in rural district of Sindh, Pakistan.

This study will be conducted in existing health infrastructure in a community setting with the help of two principal health care providers, TBAs and CHWs Community Health Workers) involved in maternal and newborn care. The TBAs conducting delivery wil be trained to wash hands with soap and water after completion of delivery and apply chlorhexidine to the Umbilical Cord Stump. The procedure will be repeated by the mother on the subsequent days up til 14 days from birth. The CHWs will also be trained to recognized signs of Omphalitis and record Cord Care in a systemic manner in a structured proforma.

The study will continue longitudinally for a period of one year to follow newborn for the signs of Omphalitis.

Study Design

Study Type:
Interventional
Actual Enrollment :
9800 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Topical Application of Chlorhexidine to the Umbilical Cord for Prevention of Omphalitis and Neonatal Mortality in Rural District of Pakistan: A Community-based Randomized Control Trial
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Sep 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: A

In this arm we recruited 2,400 subjects who received Intervention.

Drug: 4% Chlorhexidine
4% Chlorhexidine was provided to be applied in this arm to Mothers through TBAs.

Experimental: B

In this Arm, we recruited 2,400 subjects who received intervention.

Other: Hand washing Soap
Hand washing soap was provided to Mothers through TBAs.

Experimental: C

In this Arm, we recruited 2,400 subjects who received intervention.

Drug: 4% Chlorhexidine
4% Chlorhexidine was provided to be applied by Mothers through TBAs.

No Intervention: D

In this Arm, we recruited 2,400 subjects for Observation and comparison. This was the prime control group.

Outcome Measures

Primary Outcome Measures

  1. Incidence of Neonatal Omphalitis [By the end of the styudy]

  2. Rate of Neonatal Mortality [By the end of the Study]

Secondary Outcome Measures

  1. Breastfeeding rate [By the end of the Study]

  2. Rate of Serious Neonatal Infections [By the end of the Study]

  3. Utilization of Clean Delivery Kits [By the end of the Study]

  4. Application Practice of Chlorhexidine [By the end of the Study]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 28 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All healthy newborns, born in the study setting will be systematically enrolled in the trial
Exclusion Criteria:
  • Infants with congenital/birth defects

  • Infants with any localized infection on the peri-umbilical region at the time of birth or application of any other material such as dung, etc before enrollment on the Cord.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Proejct Office Dadu Sindh Pakistan 75300

Sponsors and Collaborators

  • Aga Khan University
  • John Snow, Inc.

Investigators

  • Principal Investigator: Zulfiqar Dr Bhutta, MBBS, PhD, FRCP, MRCP, The Aga Khan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00682006
Other Study ID Numbers:
  • 683-Ped/ERC-06
First Posted:
May 21, 2008
Last Update Posted:
Jul 8, 2011
Last Verified:
Jul 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2011